M&A Deal Summary |
|
|---|---|
| Date | 2012-12-26 |
| Target | Silcon Comércio Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos |
| Sector | Medical Products |
| Buyer(s) | Opko |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Life Science |
| Employees | 2,997 |
| Revenue | 713M USD (2024) |
Opko is a diversified healthcare company with a focus on establishing leading positions in significant and rapidly growing medical markets. Opko's operations are divided into diagnostics and pharmaceuticals, each with specialized products and services aimed at improving patient care and outcomes. Opko was founded in 1991 and is based in Miami, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 20 |
| Sector: Medical Products M&A | 7 of 10 |
| Type: Add-on Acquisition M&A Deals | 11 of 18 |
| Country: Brazil M&A | 1 of 1 |
| Year: 2012 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-18 |
Prost-Data
Nashville, Tennessee, United States Prost-Data, Inc. is a CLIA laboratory with 18 phlebotomy sites throughout the U.S. and an experienced national sales force calling primarily on urologists. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-03-04 |
Cytochroma
Markham, Ontario, Canada Cytochroma, Inc. is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). |
Buy | - |
